Raffit Hassan, M.D.
Laboratory of Molecular Biology
Head, Solid Tumor Immunotherapy Section
Principal Investigator
National Cancer Institute
10 Center Drive
Building 37, Room 5116
Bethesda, MD 20982
Fax: 301-402-9469
hassanr@mail.nih.gov
Dr. Hassan is a medical oncologist who completed his fellowship in oncology at NCI in 1997. He subsequently joined the faculty at the University of Oklahoma and returned to NCI as a tenure-track investigator in 2002. Dr. Hassan has focused on developing novel therapies for the treatment of malignant mesothelioma in laboratory and clinical research. He is currently conducting clinical trials of three different immunotherapy agents targeting the tumor antigen mesothelin that was discovered at NCI. In 2008 he was appointed chairman of the Science Advisory Board of the Meso Foundation. Dr. Hassan is a recipient of the American Society of Clinical Oncology Career Development Award as well as NIH’s K-23 Career Development Award.
Dr. Hassan's Clinical Trials:
NCI is currently conducting the following trials for patients with mesothelioma and solid tumors. Click on the trials below for additional details, including a summary of eligibility criteria, treatment plan, and information on how to contact the study team directly.
Back to Top
